Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
GPR120-IN-1 causes improved insulin sensitivity with increased glucose infusion rates
25(3):473-81
InChi: InChI=1S/C13H8O3/c14-8-5-6-10-9-3-1-2-4-11(9)13(15)16-12(10)7-8/h1-7
flow cytometric analysis is used to detect the cell apoptosis both in SW620 cells and Cisp-resistant SW620 cells
a highly potent
Nitazoxanide - CAS# 55981-09-4 60325 GPR120-IN-1 causes improved insulin sensitivityNitazoxanide, CAS No. 55981 09 4, is a broad spectrum antiparasitic and broad spectrum antiviral drug that is used in medicine for the treatment of various helminthic, protozoal, and viral infections. It is indicated for the treatment of infection by Cryptosporidium parvum and Giardia lamblia in immunocompetent individuals and has been repurposed for the treatment of influenza. Nitazoxanide has also been shown to have in vitro antiparasitic activity
US$ 1564.00
US$ 244.00
US$ 145.50
US$ 5085.00